ArticleTheranostics2022
TIMM44 is a potential therapeutic target of human glioma.
Yi-Zhuo Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it
ArticleTheranostics2022
Yi-Zhuo Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.